Generic Drugs in 2017: FDA on Track for Most Approvals Ever
A little more than 10 months into Fiscal Year 2017 and the US Food and Drug Administration (FDA) is on pace to break its record for abbreviated new drug application (ANDA) approvals from last year.
Continue reading on RAPS
